Rosiglitazone and lipid metabolism.
Ferrannini
E
E
Department of Internal Medicine and CNR, Institute of Clinical Physiology, University of Pisa School of Medicine, 56100 Pisa, Italy.
D000273:Adipose Tissue / Q000378:metabolism; D003920:Diabetes Mellitus / Q000188:drug therapy / Q000378:metabolism; D006801:Humans; D007004:Hypoglycemic Agents / Q000494:pharmacology*; D050356:Lipid Metabolism; D047492:Peroxisome Proliferator-Activated Receptors / Q000502:physiology; D000077154:Rosiglitazone; D045162:Thiazolidinediones / Q000494:pharmacology*
D007004:Hypoglycemic Agents; D047492:Peroxisome Proliferator-Activated Receptors; D045162:Thiazolidinediones; D000077154:Rosiglitazone